Polyhedral boron compounds as potential linkers for attachment of radiohalogens to targeting proteins and peptides.: A review

被引:41
作者
Tolmachev, V
Sjöberg, S
机构
[1] Uppsala Univ, Dept Organ Chem, SE-75121 Uppsala, Sweden
[2] Uppsala Univ, Rudbeck Lab, SE-75185 Uppsala, Sweden
关键词
tumour targeting; I-123; I-125; Br-76; At-211; polyhedral boron clusters; prosthetic groups; boranes; carboranes; isotope labelling;
D O I
10.1135/cccc20020913
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Polyhedral boron clusters (PBC) are three-dimensional inorganic aromatic systems. Some of them can easily be halogenated, and the halogen-boron bond in such systems is very strong. We consider the use of PBC as linkers for attachment of radioactive halogen isotopes to tumor-targeting proteins and peptides. In this review the major preconditions for such applications, such as biological considerations, knowledge concerning coupling chemistry and radiolabeling of PBC, are described. A review with 90 references.
引用
收藏
页码:913 / 935
页数:23
相关论文
共 91 条
[1]   BORONATION OF ANTIBODIES WITH MERCAPTOUNDECAHYDRO-CLOSO-DODECABORATE(2-) ANION FOR POTENTIAL USE IN BORON NEUTRON-CAPTURE THERAPY [J].
ALAM, F ;
SOLOWAY, AH ;
BARTH, RF .
APPLIED RADIATION AND ISOTOPES, 1987, 38 (07) :503-506
[2]  
Alberts B, 1994, MOL BIOL CELL, P508
[3]   BINDING OF EPIDERMAL GROWTH FACTOR-DEXTRAN CONJUGATES TO CULTURED GLIOMA-CELLS [J].
ANDERSSON, A ;
HOLMBERG, A ;
CARLSSON, J ;
CARLSSON, J ;
PONTEN, J ;
WESTERMARK, B .
INTERNATIONAL JOURNAL OF CANCER, 1991, 47 (03) :439-444
[4]   9-IODO-ORTHO-CARBORANE [J].
ANDREWS, JS ;
ZAYAS, J ;
JONES, M .
INORGANIC CHEMISTRY, 1985, 24 (22) :3715-3716
[5]  
[Anonymous], HDB CHEM PHYS
[6]   PET imaging in oncology [J].
Bar-Shalom, R ;
Valdivia, AY ;
Blaufox, MD .
SEMINARS IN NUCLEAR MEDICINE, 2000, 30 (03) :150-185
[7]   Reducing the renal uptake of radiolabeled antibody fragments and peptides for diagnosis and therapy: present status, future prospects and limitations [J].
Behr, TM ;
Goldenberg, DM ;
Becker, W .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1998, 25 (02) :201-212
[8]  
BEHR TM, 1995, CANCER RES, V55, P3825
[9]  
Behr TM, 1996, J NUCL MED, V37, P829
[10]  
BOEMAN OC, 2000, SEMIN NUCL MED, V30, P195